SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-19-008756
Filing Date
2019-10-01
Accepted
2019-10-01 18:43:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3.htm S-3 575753
2 EX-4.7 ex-4d7.htm EX-4.7 575627
3 EX-5.1 ex-5d1.htm EX-5.1 39487
4 EX-23.1 ex-23d1.htm EX-23.1 3252
5 GRAPHIC ex-5d1g001.jpg GRAPHIC 1431
6 GRAPHIC s-3g001.jpg GRAPHIC 8037
  Complete submission text file 0001558370-19-008756.txt   1208407
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234034 | Film No.: 191130437
SIC: 2834 Pharmaceutical Preparations